{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:58:13Z","timestamp":1784372293053,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.molmed.2011.01.005","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T21:18:44Z","timestamp":1299532724000},"page":"276-282","source":"Crossref","is-referenced-by-count":121,"title":["Disease-associated amyloid and misfolded protein aggregates activate the inflammasome"],"prefix":"10.1016","volume":"17","author":[{"given":"Seth L.","family":"Masters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.J.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2011.01.005_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.01.005_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.01.005_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.molmed.2011.01.005_bib0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.01.005_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0050","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1002396107","article-title":"Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis","volume":"107","author":"Meissner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0055","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.01.005_bib0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.immunol.23.021704.115616","article-title":"CATERPILLER: a novel gene family important in immunity, cell death, and diseases","volume":"23","author":"Ting","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0075","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1074\/jbc.M608083200","article-title":"ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages","volume":"282","author":"Cruz","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.01.005_bib0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.01.005_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0090","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1182\/blood-2009-10-250803","article-title":"Human NLRP3 inflammasome activation is Nox1-4 independent","volume":"115","author":"van Bruggen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.01.005_bib0095","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1073\/pnas.0914795107","article-title":"Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease","volume":"107","author":"van de Veerdonk","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0115","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","article-title":"Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans","volume":"232","author":"Bendtzen","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.01.005_bib0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/diabetes.37.7.916","article-title":"Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1","volume":"37","author":"Eizirik","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2011.01.005_bib0125","first-page":"R794","article-title":"Interleukin 1 affects glucose homeostasis","volume":"253","author":"del Rey","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0026-0495(94)90093-0","article-title":"Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake","volume":"43","author":"Ling","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.molmed.2011.01.005_bib0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00401200","article-title":"Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats","volume":"35","author":"Wogensen","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2011.01.005_bib0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2011.01.005_bib0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MED.0b013e32833bf6dc","article-title":"Role of IL-1beta in type 2 diabetes","volume":"17","author":"Dinarello","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.molmed.2011.01.005_bib0150","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","article-title":"IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat","volume":"106","author":"Ehses","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1006\/bbrc.1994.1962","article-title":"Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice","volume":"202","author":"Sandberg","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2011.01.005_bib0160","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2007-1059","article-title":"The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia","volume":"149","author":"Sauter","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2011.01.005_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2008.07.004","article-title":"Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity","volume":"44","author":"Osborn","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2011.01.005_bib0170","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/en.2009-1124","article-title":"XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model","volume":"151","author":"Owyang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2011.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2011.01.005_bib0185","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0190","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2011.01.005_bib0200","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","article-title":"Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes","volume":"53","author":"Butler","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2011.01.005_bib0205","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0210","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0215","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","article-title":"Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?","volume":"53","author":"Zraika","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2011.01.005_bib0220","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1210\/jc.2008-0396","article-title":"Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation","volume":"93","author":"Boni-Schnetzler","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2011.01.005_bib0225","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2011.01.005_bib0230","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.2337\/diabetes.54.11.3238","article-title":"Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?","volume":"54","author":"Welsh","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2011.01.005_bib0235","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2009-0543","article-title":"Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I","volume":"150","author":"Boni-Schnetzler","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2011.01.005_bib0240","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Fatty acids engagement with TLR2 drive IL-1beta production via ASC-caspase-1 activation by urate crystals in gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2011.01.005_bib0245","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00125-010-1747-3","article-title":"Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet","volume":"53","author":"Ehses","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2011.01.005_bib0365","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"12","author":"Stienstra","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2011.01.005_bib0370","doi-asserted-by":"crossref","unstructured":"Vandanmagsar, B. et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med.","DOI":"10.1038\/nm.2279"},{"key":"10.1016\/j.molmed.2011.01.005_bib0250","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI31450","article-title":"Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology","volume":"117","author":"Shaftel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2011.01.005_bib0255","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S0958067099018928","article-title":"Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission","volume":"84","author":"O\u2019Connor","year":"1999","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0260","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hipo.10164","article-title":"Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation","volume":"14","author":"Depino","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.molmed.2011.01.005_bib0265","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-4159.2006.03872.x","article-title":"Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release","volume":"98","author":"Thornton","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2011.01.005_bib0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molmed.2011.01.005_bib0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-5728(96)00030-6","article-title":"beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes","volume":"67","author":"Lorton","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","article-title":"Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia","volume":"74","author":"Yates","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2011.01.005_bib0285","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","article-title":"S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha","volume":"31","author":"Bianchi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.01.005_bib0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/40299","article-title":"Inhibition of ICE slows ALS in mice","volume":"388","author":"Friedlander","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0300","doi-asserted-by":"crossref","first-page":"15763","DOI":"10.1073\/pnas.95.26.15763","article-title":"Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase","volume":"95","author":"Pasinelli","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.01.005_bib0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.01.005_bib0310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0315","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2011.01.005_bib0320","first-page":"302","article-title":"Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)","volume":"67","author":"Bodar","year":"2009","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.molmed.2011.01.005_bib0325","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.01.005_bib0330","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.01.005_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.01.005_bib0340","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","author":"Nakahira","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2011.01.005_bib0375","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","article-title":"Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)","volume":"108","author":"Lobito","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.01.005_bib0380","doi-asserted-by":"crossref","unstructured":"Bulua, A.C. et al. (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med.","DOI":"10.1084\/jem.20102049"},{"key":"10.1016\/j.molmed.2011.01.005_bib0345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.23164","article-title":"Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis","volume":"58","author":"Galocha","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2011.01.005_bib0350","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"Suppl 3","key":"10.1016\/j.molmed.2011.01.005_bib0355","first-page":"178","article-title":"Safe, rapid-onset, and sustained biological activity of IL-1 beta regulating antibody XOMA 052 in resistant uveitis of Beh\u00e7et's disease: preliminary results of a pilot trial","volume":"69","author":"G\u00fcl","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2011.01.005_bib0360","first-page":"203","article-title":"A possible role for catabolin in tissue remodelling and repair","volume":"86","author":"Dingle","year":"1981","journal-title":"Ciba Found. Symp."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T02:13:53Z","timestamp":1637374433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491411000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1471491411000062"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2011.01.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}